Akums Drugs and Pharmaceuticals Limited — Board Meeting, 09-11-2024: Outcome of Board Meeting

Akums Drugs and Pharmaceuticals reported its unaudited financial results for the quarter and half-year ended September 30, 2024. The company announced a net profit of ₹66.65 million, with total income of ₹10,465.57 million. Additionally, it discussed a postal ballot for shareholder approval regarding rewards for its promoters related to the recent IPO. The Board also appointed a scrutinizer for the e-voting process. Further details and the review report from the auditors are enclosed.